NF-κB activity has been linked to the pathogenesis of T2D, metabolic syndrome, and related complications [263, 278, 279] by promoting the expression of a number of proinflammatory cytokines including TNF-α, IL-1, and IL-6. The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.